Do Pharma Boards Meet Their Responsibilities?
4/26/2012 8:25:53 AM
One aspect of the drug companies worth examining concerns the way they're governed. The value of scrutinizing directors and top managers in pharma consists of learning to distinguish good from bad leadership in a research-driven industry that requires 10 years or more to develop its new products. If setting companies on the wrong course can take most of a decade to correct, it makes sense to find the best ways of starting them right and keeping them that way.
comments powered by